3.0.0 4489 2023-01-11T13:16:45Z 2023-01-11T13:16:45Z House H HR 2010-01-21 111 hsgo00 Oversight and Accountability Committee House Standing hsgo25 Information Technology Subcommittee Reported by 2010-03-24T13:13:13Z Markup by 2010-03-24T13:12:44Z Hearings by 2010-02-23T19:58:41Z Referred to 2010-02-12T21:38:21Z Referred to 2010-01-21T15:02:47Z 2010-03-24 hsgo25 Information Technology Subcommittee 1 House committee actions Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . Committee 2010-03-24 hsgo25 Information Technology Subcommittee 1 House committee actions Subcommittee Consideration and Mark-up Session Held. Committee 2010-02-23 hsgo25 Information Technology Subcommittee 1 House committee actions Subcommittee Hearings Held. Committee 2010-02-12 hsgo25 Information Technology Subcommittee 1 House committee actions Referred to the Subcommittee on Federal Workforce, Post Office, and the District of Columbia. Committee 2010-01-21 Referred to the House Committee on Oversight and Government Reform. IntroReferral H11100 2 House floor actions hsgo00 Oversight and Accountability Committee 2010-01-21 Sponsor introductory remarks on measure. (CR E70-71) IntroReferral B00100 9 Library of Congress 2010-01-21 Introduced in House IntroReferral Intro-H 9 Library of Congress 2010-01-21 Introduced in House IntroReferral 1000 9 Library of Congress L000562 Rep. Lynch, Stephen F. [D-MA-9] Stephen Lynch D MA F. 9 N C001078 Rep. Connolly, Gerald E. [D-VA-11] Gerald Connolly D VA E. 11 2010-01-21 True C000984 Rep. Cummings, Elijah E. [D-MD-7] ELIJAH CUMMINGS D MD E. 7 2010-01-21 True D000399 Rep. Doggett, Lloyd [D-TX-25] LLOYD DOGGETT D TX 25 2010-02-22 False C001049 Rep. Clay, Wm. Lacy [D-MO-1] WM. CLAY D MO LACY 1 2010-03-11 False N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] ELEANOR NORTON D DC HOLMES 0 2010-03-11 False K000336 Rep. Kucinich, Dennis J. [D-OH-10] DENNIS KUCINICH D OH J. 10 2010-03-11 False W000792 Rep. Weiner, Anthony D. [D-NY-9] ANTHONY WEINER D NY D. 9 2010-03-11 False H001043 Rep. Hodes, Paul W. [D-NH-2] Paul Hodes D NH W. 2 2010-03-20 False D000609 Rep. Driehaus, Steve [D-OH-1] Steve Driehaus D OH 1 2010-03-20 False C001080 Rep. Chu, Judy [D-CA-32] Judy Chu D CA 32 2010-04-15 False D000210 Rep. Delahunt, Bill [D-MA-10] Bill Delahunt D MA 10 2010-04-15 False M000933 Rep. Moran, James P. [D-VA-8] JAMES MORAN D VA P. 8 2010-04-22 False V000108 Rep. Visclosky, Peter J. [D-IN-1] PETER VISCLOSKY D IN J. 1 2010-04-22 False F000116 Rep. Filner, Bob [D-CA-51] BOB FILNER D CA 51 2010-04-22 False S001156 Rep. Sánchez, Linda T. [D-CA-39] Linda Sánchez D CA T. 39 2010-05-27 False M001146 Rep. Marshall, Jim [D-GA-8] Jim Marshall D GA 8 2010-09-14 False Government Operations and Politics Business records Consumer affairs Government employee pay, benefits, personnel management Health care costs and insurance Prescription drugs Public contracts and procurement Government Operations and Politics 00 2010-01-21 Introduced in House 2010-06-24T15:23:38Z FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with requirements of this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply.

Prohibits: (1) a pharmaceutical drug manufacturer or retail pharmacy from having a controlling interest in the PBM; or (2) the PBM from having a controlling interest in a retail pharmacy. Requires each carrier to certify PBM compliance annually. Prohibits OPM from permitting a carrier that has a controlling interest in a PBM to earn a profit from such interest with respect to an FEHBP contract.

Sets forth requirements of PBM arrangements under the FEHBP, including regarding: (1) drug substitution restrictions; (2) PBM reimbursement of carriers; (3) sale by a PBM of utilization and claims data; (4) drug pricing and the basis for reimbursement; (5) provisions of an explanation of benefits to enrollees; (6) nondiscriminatory contracts regarding required participation; (7) OPM access to PBM contract information; (8) civil monetary penalties for making false statements or claims to the government; and (9) reports from drug manufacturers on average manufacturer prices for drugs each quarter.

]]> FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act Display Title FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act Official Title as Introduced To amend chapter 89 of title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program. Introduced in House IH Short Titles as Introduced FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act Introduced in House 2010-01-21T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-111hr4489ih/xml/BILLS-111hr4489ih.xml 2010-03-24 Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.